[Endocannabinoids receptor blocker lets tumble not only money. A drug against metabolic syndrome?].
Aumiller
Jochen
J
D001920:Bradykinin / Q000037:antagonists & inhibitors*; D063387:Cannabinoid Receptor Antagonists; D002186:Cannabinoids / Q000037:antagonists & inhibitors*; D017326:Clinical Trials, Phase III as Topic; D004311:Double-Blind Method; D006801:Humans; D024821:Metabolic Syndrome / Q000188:drug therapy*; D010880:Piperidines / Q000008:administration & dosage / Q000627:therapeutic use*; D010919:Placebos; D011720:Pyrazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D000077285:Rimonabant; D013997:Time Factors; D015431:Weight Loss
D063387:Cannabinoid Receptor Antagonists; D002186:Cannabinoids; D010880:Piperidines; D010919:Placebos; D011720:Pyrazoles; D000077285:Rimonabant; D001920:Bradykinin